Down-regulated expression of transforming growth factor beta 1 mRNA in endometrial carcinoma

British Journal of Cancer

Volumn 77, Issue 8, 1998, Pages 1260-1266

  Perlino, E ^a   Loverro, G ^b   Maiorano, E ^b   Giannini, T ^a   Cazzolla, A ^b   Napoli, A ^b   Fiore, M G ^b   Ricco, R ^b   Marra, E ^a   Selvaggi, L ^b  

^a CNR   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Adenocarcinoma; Immunohistochemistry; Northern blotting; RNA expression; Transforming growth factor 1; Uterus

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 6844240210     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.211     Document Type: Article

References (34)

1. Barnard JA, Lyons RM and Moses HI (1990) The cell biology of transforming growth factor β. Biochim Biophys Acta 1032: 79-87
2. Berchuck A and Boyd J (1995) Molecular basis of endometrial cancer. Cancer (suppl.) 76: 2034-2040
3. Bhatia P, Taylor WR, Greenberg AH and Wright JA (1994) Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for Northern blot analysis of cell lines of varying malignant potential. Ann Biochem 216: 223-226
4. Boyd JA and Kaufman DG (1990) Expression of transforming growth factor β1 by human endometrial carcinoma cell lines: inverse correlation with effect on growth rate and morphology. Cancer Res 50: 3394-3399
5. Casey ML and Macdonald PC (1996) The endothelin parathyroid hormone-related protein vasoactive peptide system in human endometrium: modulation by tansforming growth factor β. Human Reprod 11: 62-82
6. Chegim N, Zao Y, Williams RS and Flanders KC (1994) Human uterine tissue throughout the menstrual cycle expresses transforming growth factor β1 (TGF-β1). TGF-β2 and transforming growth factor-β3 and TGF-β Type II receptor for messenger ribonucleic acid and protein and contains [IC1]TGF-β1-binding sites. Endocrinology 135: 439-449
7. Chirgwin JM, Przybyla AE, Raymond JM and Rutter WJ (1979) Isolation of biologically active ribonucleic acid from source enriched in ribonuclease. Biochemistry 18: 5294-5299
8. Christeli E, Zoumpourlis V, Kiaris H, Ergazaki M, Vassilaros S and Spandidos DA (1996) TGF-β1 overexpression in breast cancer: correlation with climicopathological data. Oncol Reports 3: 1115-1118
9. Cline MJ (1996) Overview: the nature of malignancy. In Apoptosis and Cell Cycle Control in Cancer. Shaun N and Thomas B (eds). pp. 131-146. Latchman: London
10. Coffey RJ, Goustin AS, Soderquist AM, Shipley GD, Wolfshohl J, Carpenter G and Moses HI. (1987) Transforming growth factor α and β expression in human colon cancer lines: implications for an autocrine model. Cancer Res 47: 4590-4594
11. Derynck R, Jarret JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB and Goeddel DV (1985) Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701-705
12. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS and Berger WH (1987) Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707-712
13. Feuerstein N and Cooper HI. (1984) Studies of differentiation of promyelocytic cells by phorbol ester. Biochim Biophys Acta 781: 239-246
14. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI and Kore M (1994) Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105: 1846-1856
15. Giudice LC (1994) Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproduction medicine. Fertil Steril 61: 1-17
16. Gold LI, Saxena B, Mittal KR, Marmor M, Goswami S, Nactigal L, Korc M and Demoupoulos RI (1994) Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 54: 2347-2358
17. Gurpide E (1991) Endometrial cancer: biochemical and clinical correlates, J Natl Cancer Inst 83: 405-416
18. Jetten AM, Shirley JE and Stoner G (1986) Regulation of proliferation and differentiation of respiratory tract epithelial cells by TGF-β Exp Cell Res 167: 539-549
19. Kauma S, Matt D, Strom S, Eierma D and Turner T (1990) Interleukin-1b. human leukocyte antigen HLA-DRα and transforming growth factor-β expression in endometrium. placenta and placental membranes. Am J Obstet Gynecol 163: 14130-14137
20. Kimchi A, Wang X-F, Weinberg RA, Cheietz S and Massagué J (1988) Absence of TGF-β receptor and growth inhibitory responses in retinoblastoma cells. Science 240: 196-198
21. McMahon JB, Richards WL, del Campo AA, Song MK and Thorgiersson SS (1986) Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res 46: 4665-4571
22. Marshburn PB, Arici AM and Casey ML (1994) Expression of transforming growth factor-β1 messenger ribonucleic acid and the modulation of deoxyribonucleic acid synthesis by transforming growth factor-β1 in human endometrial cells. Am J Obstet Gynecol 170: 1152-1158
23. Massaguë J (1990) The transforming growth factor-β family. Annu Rev Cell Biol 6: 597-641
24. Murphy LJ, Gong Y and Murphy LC (1991) Growth factors in normal and malignant tissue. Ann NY Acad Sci 622: 183-401
25. Niitsu Y, Urushizaki Y, Koshida Y, Terui K, Mahara K, Kohgo Y and Urushizaki I (1988) Expression of TGF-β gene in adult T-cell leukemia. Blood 71: 263-266
26. Paulin C, Avallet O, Tardy F, Saez J, Fusco A and Fabien N (1995) Production of TGF-β and HGF receptor by a differentiated papillary thyroid carcinoma cell line (B-CPAP): implication in malignancy. Int J Oncol 7: 657-660
27. Perlino E, Ciampolillo A, Maiorano E, Pannone E, Viale G, Giorgino; R and Marra E (1996) Transforming growth factor-β1 (TGF-β1) expression in proliferating thyroid disease. Int J Oncol 9: 83-88
28. Reiss M and Sartorelli AC (1987) Regulation of growth and differentiation of human keratinocyte by type β transforming growth factor and epidermal growth factor. Cancer Res 47: 6705-6709
29. Roberts AB and Sporn MB (1990) The transforming growth factor-βs In Peptide Growth Factors and their Res eptors, Sporn MB and Roberts AB (eds). pp. 419-472. Springer: Heidelberg
30. Smith SK (1994) Growth factor in the human endometriuin. Human Reprod Update 9: 936-946
31. Tabibzadeh S (1991) Human endometrium: an active site of cytokine production and action. Endocrinol Rev 12: 272-290
32. Tang X-M, Zhao Y, Rossi MY, Abu-Rustum RS, Ksander GA and Ghegini N (1994) Expression of Transforming Growth Factor-β (TGF-β) isoforms and TGF-β type II receptor messenger ribonucleic acid and protein, and the effect of TGF-βs on endometrial stromal cells growth and protein degradation in vitro. Endocrinology 135: 450-459
33. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT and Thompson TC (1993) Association of transforming growth factor β1 with prostate cancer. Human Pathol 24: 4-9
34. Van Noorden S (1986). Tissue preparation and immunostaining for light microscopy. In Immunocytochemistry. Modern Methords and Applications, Polak JM and Van Noorden S (eds). pp. 26 53. Wright: Bristol. UK